blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2063880

EP2063880 - COMPOSITION FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.06.2010
Database last updated on 17.09.2024
Most recent event   Tooltip18.06.2010Application deemed to be withdrawnpublished on 21.07.2010  [2010/29]
Applicant(s)For all designated states
GEMAC
12, rue Condorcet
33150 Cenon / FR
[2009/23]
Inventor(s)01 / GEFFARD, Michel
200 avenue de Thouars
F-33400 Talence / FR
 [2009/23]
Representative(s)Cenatiempo, Julie Adeline Anne
Société Aquinov Allée de la Forestière
33750 Beychac et Caillau / FR
[N/P]
Former [2009/23]Cenatiempo, Julie Adeline Anne
Société Aquinov Allée de la Forestière
F-33750 Beychac et Caillau / FR
Application number, filing date07823842.517.09.2007
[2009/23]
WO2007FR51947
Priority number, dateFR2006005378918.09.2006         Original published format: FR 0653789
[2009/23]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report
No.:WO2008035001
Date:27.03.2008
Language:FR
[2008/13]
Type: A2 Application without search report 
No.:EP2063880
Date:03.06.2009
Language:FR
The application published by WIPO in one of the EPO official languages on 27.03.2008 takes the place of the publication of the European patent application.
[2009/23]
Search report(s)International search report - published on:EP22.05.2008
ClassificationIPC:A61K31/198, A61K31/185, A61K31/20, A61K31/201, A61K31/203, A61K38/04, A61P25/28, A61P21/00
[2009/23]
CPC:
A61K47/12 (EP,US); A61K31/185 (EP,US); A61K31/198 (EP,US);
A61K31/20 (EP,US); A61K31/201 (EP,US); A61K31/203 (EP,US);
A61K38/04 (EP,US); A61K47/42 (EP,US); A61P21/00 (EP);
A61P25/00 (EP); A61P25/28 (EP); A61P39/06 (EP) (-)
C-Set:
A61K31/185, A61K2300/00 (EP,US);
A61K31/198, A61K2300/00 (US,EP);
A61K31/201, A61K2300/00 (US,EP);
A61K31/203, A61K2300/00 (EP,US);
A61K31/20, A61K2300/00 (US,EP);
A61K38/04, A61K2300/00 (EP,US)
(-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/23]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:ZUSAMMENSETZUNG FÜR DIE BEHANDLUNG VON AMYOTROPHER LATERALSKLEROSE[2009/23]
English:COMPOSITION FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS[2009/23]
French:COMPOSITION DESTINEE AU TRAITEMENT DE LA SCLEROSE LATERALE AMYOTROPHIQUE[2009/23]
Entry into regional phase13.03.2009National basic fee paid 
13.03.2009Designation fee(s) paid 
13.03.2009Examination fee paid 
Examination procedure13.03.2009Examination requested  [2009/23]
02.07.2009Despatch of a communication from the examining division (Time limit: M06)
13.01.2010Application deemed to be withdrawn, date of legal effect  [2010/29]
16.02.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/29]
Fees paidRenewal fee
24.09.2009Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XA]FR2727117  (GEFFARD MICHEL [FR]) [X] 1,2,4 * pages 21-22; example 2 * * claims 1-7 * * page 8, line 30 - page 9, line 4 * * page 2, lines 22-25 * [A] 5;
 [X]WO9615810  (GEFFARD MICHEL [FR]) [X] 1,2,4 * sentence 1 * * page 3, lines 22-32 * * pages 21-22; example 2 *;
 [PX]WO2006125930  (GEMAC [FR], et al) [PX] 1,2 * the whole document *;
 [PX]FR2886153  (GEMAC SA [FR]) [PX] 1,2 * page 6, lines 9-11; claims 1,2,11 * * pages 8-9; example 1 *;
 [A]  - JACKSON M ET AL, "THERAPEUTIC DEVELOPMENTS IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS", EXPERT OPINION ON INVESTIGATIONAL DRUGS, ASHLEY PUBLICATIONS LTD., LONDON, GB, (20021001), vol. 11, no. 10, ISSN 1354-3784, pages 1343 - 1364, XP008035103 [A] 1,2,4,5 * the whole document *

DOI:   http://dx.doi.org/10.1517/13543784.11.10.1343
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.